For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $2.96 in the last session, up 10.24% from day before closing price of $2.68. In other words, the price has increased by $10.24 from its previous closing price. On the day, 1.04 million shares were traded.
Ratios:
We take a closer look at ALDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Machatha Stephen sold 16,041 shares of ALDX for $75,975 on Aug 12 ’24. The Chief Development Officer now owns 236,771 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the insider of the company, sold 10,834 shares for $4.74 each. As a result, the insider received 51,313 and left with 126,382 shares of the company.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 22.52%, while the 200-Day Moving Average is calculated to be -37.93%.
Shares Statistics:
A total of 60.05M shares are outstanding, with a floating share count of 58.15M. Insiders hold about 2.92% of the company’s shares, while institutions hold 56.16% stake in the company.
